US FDA Plans Move Inspectorate Back To More Generalist Organization

 
• By Sarah Karlin-Smith and Derrick Gingery
  
Two people inspecting a manufacturing facility.
The FDA's inspectorate is set to revert back to a more generalist team. (Shutterstock)

More from Compliance

More from Medtech Insight